Published in Br J Pharmacol on April 01, 2012
Eosinophil apoptosis and clearance in asthma. J Cell Death (2013) 0.81
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Resolution of inflammation: state of the art, definitions and terms. FASEB J (2007) 5.12
In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood (2010) 4.84
Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med (2007) 4.56
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J (2005) 3.66
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol (2009) 3.32
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol (2002) 2.83
Neutrophil kinetics in health and disease. Trends Immunol (2010) 2.47
Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance. Am J Respir Crit Care Med (2000) 2.06
Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med (1997) 1.84
Neutrophil apoptosis and clearance from neonatal lungs. Lancet (1991) 1.76
Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol (2005) 1.74
Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J (2005) 1.72
Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol (2001) 1.65
Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis (2008) 1.57
Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol (2008) 1.55
Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol (2007) 1.55
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Clin Exp Allergy (2011) 1.53
Transepithelial exit of leucocytes: inflicting, reflecting or resolving airway inflammation? Thorax (2010) 1.51
Science review: apoptosis in acute lung injury. Crit Care (2003) 1.45
Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients. Respir Med (2010) 1.41
Airway epithelial cells promote transmigration of eosinophils in a new three-dimensional chemotaxis model. Clin Exp Allergy (2002) 1.40
Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med (2000) 1.32
Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol (2001) 1.30
Immune-mediated emigration of neutrophils into the lumen of the small intestine. Infect Immun (1974) 1.27
Neutrophils and lung injury: getting it right. J Clin Invest (2002) 1.24
The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol (2006) 1.22
Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol (1998) 1.21
Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med (2001) 1.21
Reverse leukocyte migration can be attractive or repulsive. Trends Cell Biol (2008) 1.21
Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax (2006) 1.14
In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol (2008) 1.11
Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol (1998) 1.11
Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol Sci (2006) 1.10
Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect (2011) 1.07
Doubts concerning the recently reported human neutrophil lifespan of 5.4 days. Blood (2011) 1.06
Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am J Respir Crit Care Med (2004) 1.06
Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med (2009) 1.06
Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax (2005) 1.04
Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. Am J Respir Crit Care Med (2001) 1.01
Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2 deficient mice results in extended hyperresponsiveness. Immunity (1999) 0.98
Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci (1997) 0.96
Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir Res (2005) 0.95
Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration. Thorax (2004) 0.94
Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax (2004) 0.93
Resolving the problem of persistence in the switch from acute to chronic inflammation. Proc Natl Acad Sci U S A (2007) 0.92
Airway neutrophilia in COPD is not associated with increased neutrophil survival. Eur Respir J (2006) 0.91
Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology (1986) 0.91
Targeting the networks that underpin contiguous immunity in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 0.89
Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy (2006) 0.88
Altered allergen-induced eosinophil trafficking and physiological dysfunction in airways with preexisting virus-induced injury. Am J Physiol Lung Cell Mol Physiol (2006) 0.88
Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction. Eur Respir J (1993) 0.87
Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol (1992) 0.87
Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression. J Immunol (2008) 0.85
Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis (1991) 0.83
Targeted therapies in inflammatory bowel disease. Dig Dis (2009) 0.83
Unbalanced research. Trends Pharmacol Sci (2001) 0.83
CX₃CR1 is critical for Salmonella-induced migration of dendritic cells into the intestinal lumen. Gut Microbes (2010) 0.83
Paradoxical pharmacology: turning our pharmacological models upside down. Trends Pharmacol Sci (2011) 0.81
Generation of clusters of free eosinophil granules (Cfegs) in seasonal allergic rhinitis. Allergy (1998) 0.80
Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J Allergy Clin Immunol (1996) 0.79
Resolution of cell-mediated airways diseases. Respir Res (2010) 0.79
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand J Clin Lab Invest (2010) 0.78
Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis. Respir Res (2010) 0.78
Epithelial Rho GTPases and the transepithelial migration of lymphocytes. Methods Enzymol (2008) 0.77
Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics. Thorax (2004) 0.77
Eosinophilic inflammation: life, death and apoptosis. Clin Exp Allergy (2011) 0.76
Transepithelial exit of leucocytes: inflicting, reflecting or resolving airway inflammation? Thorax (2010) 1.51
Interferon regulatory factor 3 activation mediates viral stimulus-induced bronchial production of thymic stromal lymphopoietin. J Allergy Clin Immunol (2013) 1.08
Allergen exposure of mouse airways evokes remodeling of both bronchi and large pulmonary vessels. Am J Respir Crit Care Med (2004) 1.07
Viral stimuli trigger exaggerated thymic stromal lymphopoietin expression by chronic obstructive pulmonary disease epithelium: role of endosomal TLR3 and cytosolic RIG-I-like helicases. J Innate Immun (2011) 0.92
Neutrophil cannibalism--a back up when the macrophage clearance system is insufficient. Respir Res (2006) 0.92
dsRNA-induced expression of thymic stromal lymphopoietin (TSLP) in asthmatic epithelial cells is inhibited by a small airway relaxant. Pulm Pharmacol Ther (2010) 0.88
Remodeling of extra-bronchial lung vasculature following allergic airway inflammation. Respir Res (2008) 0.85
Primary lysis of eosinophils as a major mode of activation of eosinophils in human diseased tissues. Nat Rev Immunol (2013) 0.82
Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma. Am J Respir Crit Care Med (2014) 0.81
Rhinovirus and dsRNA induce RIG-I-like receptors and expression of interferon β and λ1 in human bronchial smooth muscle cells. PLoS One (2013) 0.81
Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors. Br J Pharmacol (2013) 0.81
Capacity of capsazepinoids to relax human small airways and inhibit TLR3-induced TSLP and IFNβ production in diseased bronchial epithelial cells. Int Immunopharmacol (2012) 0.80
Resolution of cell-mediated airways diseases. Respir Res (2010) 0.79
Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem (2006) 0.77
HH Salter (1860s): taking cold as original cause and provocative of attacks of asthma. Thorax (2013) 0.77
Allergic airway inflammation initiates long-term vascular remodeling of the pulmonary circulation. Int Arch Allergy Immunol (2009) 0.76
TRPV4-mediated calcium influx and ciliary activity in human native airway epithelial cells. Basic Clin Pharmacol Toxicol (2013) 0.76
Letter to Respiratory Medicine: "Drugs reducing transepithelial leukocyte traffic may worsen lung disease". Respir Med (2011) 0.75
Simvastatin-induced effects on bronchial epithelial cells from COPD donors. Eur Respir J (2013) 0.75
'To measure is to know' (Lord Kelvin). Respirology (2014) 0.75
Increased fecal leukocytes may reflect resolution of IBD. Scand J Gastroenterol (2010) 0.75